1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT
Manesh R. Patel(Duke University), Jonathon Leipsic(University of British Columbia), Niels Peter Rønnow Sand(University of Southern Denmark), Jeroen Sonck(Cardiovascular Research Center), Michael Poon(Northwell Health), Bjarne Linde Nørgaard(Aarhus University), Tomohiro Kawasaki(Koga Hospital), Tetsuya Amano(Aichi Medical University), Campbell Rogers(HeartFlow (United States)), Lynne Koweek(Duke University), Bernard De Bruyne(Al-Azhar University), Jeroen J. Bax(Leiden University), Koen Nieman(University of British Columbia), Mark Rabbat(Loyola University Chicago), Kristian Altern Øvrehus(Odense University Hospital), Gianluca Pontone(University of Milan), Jesper Møller Jensen(Aarhus University Hospital), Gilbert Raff, Hitoshi Matsuo, Timothy Fairbairn(University of Liverpool), Takashi Akasaka(Sakurabashi Watanabe Hospital), Daniel S. Berman(Cedars-Sinai Medical Center), Sarah Mullen(HeartFlow (United States))
Cited by 309
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
|European Heart Journal|2011|3.5k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
|European Journal of Heart Failure|2008|3.5k